Search Results - "KUTER, B"

Evaluation of oral health status and oral disorders of children with autism spectrum disorders by gender by Kuter, B., Uzel, I.

“…The aim of this study was to evaluate whether there is a relationship between gender and oral health status of children with autism spectrum disorders (CASD)…”
Get full text

Economic burden of varicella in children 1-12 Years of age in Hungary, 2011-2015 by Meszner, Z, Molnar, Z, Rampakakis, E, Yang, H K, Kuter, B J, Wolfson, Lara J

“…Although live-attenuated varicella-zoster virus (VZV) vaccines have been proven to be safe and effective in preventing varicella and real-word evidence shows…”
Get full text

Burden of Varicella in Latin America: A Systematic Review and Critical Analysis by Yang, H.K, Liaw, K.L, Manoff, S, Kuter, B

Get full text

Burden of Varicella in Eastern Europe: A Systematic Review and Critical Analysis by Yang, H.K, Song, K.M, Manoff, S, Liaw, K.L, Kuter, B

Get full text

The effect of heat on the mechanical properties of glass ionomer cements by Kuter, B, Eden, E, Yildiz, H

“…The objective of this study was to assess the effect of heat application on the mechanical properties of glass ionomer cements. experimental design. The effect…”
Get full text

A study of RotaTeq™ (pentavalent rotavirus vaccine) in Chinese healthy adults, children and infants by Lawrence, J, He, S, Hille, D, Shen, C, Kuter, B, Schodel, F, Li, R

Get full text

Administration of hepatitis A vaccine at 6 and 12 months of age concomitantly with hexavalent (DTaP–IPV–PRP∼T–HBs) combination vaccine by Stojanov, S, Liese, J.G, Belohradsky, B.H, Vandermeulen, C, Hoppenbrouwers, K, Van der Wielen, M, Van Damme, P, Georges, B, Dupuy, M, Scemama, M, Watson, M, Fiquet, A, Stek, J.E, Golm, G.T, Schödel, F.P, Kuter, B.J

“…Abstract Background Administration of two doses of hepatitis A (HA) vaccine to children ≥2 years of age has been shown to be protective. The present study…”
Get full text

Six Years' Follow-up after Hepatitis A Vaccination by Werzberger, Alan, Kuter, Barbara, Nalin, David

“…To the Editor: Epidemics of hepatitis A occurred in four of the six years preceding the Monroe efficacy trial 1 of an inactivated hepatitis A vaccine (VAQTA)…”
Get full text

Varicella vaccine (VARIVAX) in healthy children and adolescents : results from clinical trials, 1987 to 1989 by JO WHITE, C, KUTER, B. J, HILDEBRAND, C. S, ISGANITIS, K. L, MATTHEWS, H, MILLER, W. J, PROVOST, P. J, ELLIS, R. W, GERETY, R. J, CALANDRA, G. B

“…A total of 3303 healthy children and adolescents, aged 12 months to 17 years, were vaccinated with one of five production lots of a live attenuated varicella…”
Get full text

Randomized, Double-Blind Study in Healthy Adults to Assess the Boosting Effect of Vaqta or Havrix after a Single Dose of Havrix by Connor, Bradley A., Phair, John, Sack, David, McEniry, David, Hornick, Richard, Banerjee, Dalfoni, Jensen, Erin, Kuter, Barbara

“…A randomized, double-blind, multicenter study was conducted to investigate the boosting effect of Vaqta or Havrix in 537 healthy adults 18–53 years of age who…”
Get full text

Evaluation of mRNA-1273 Vaccine in Children 6 Months to 5 Years of Age by Anderson, Evan J., Creech, C. Buddy, Berthaud, Vladimir, Piramzadian, Arin, Johnson, Kimball A., Zervos, Marcus, Garner, Fredric, Griffin, Carl, Palanpurwala, Khozema, Turner, Mark, Gerber, Jeffrey, Bennett, Richard L., Ali, Kashif, Ampajwala, Madhavi, Berman, Gary, Nayak, Jennifer, Chronis, Carey, Rizzardi, Barbara, Muller, William J., Smith, Christopher A., Fuchs, George, Hsia, Daniel, Tomassini, Joanne E., DeLucia, Dianne, Reuter, Caroline, Kuter, Barbara, Zhao, Xiaoping, Deng, Weiping, Zhou, Honghong, Ramirez Schrempp, Daniela, Hautzinger, Kelly, Girard, Bethany, Slobod, Karen, McPhee, Roderick, Pajon, Rolando, Aunins, Anne, Das, Rituparna, Miller, Jacqueline M., Schnyder Ghamloush, Sabine

“…In a randomized, placebo-controlled trial involving children 6 months to 5 years of age, the mRNA-1273 vaccine was shown to be safe, and the elicited antibody…”
Get full text

Duration of protection from clinical hepatitis A disease after vaccination with VAQTA by Wiens, Brian L., Bohidar, Norman R., Pigeon, Joseph G., Egan, James, Hurni, William, Brown, Leora, Kuter, Barbara J., Nalin, David R.

“…Recent papers examining the expected persistence of anti‐hepatitis A virus antibody following vaccination with inactivated hepatitis A vaccine have estimated…”
Get full text

Measles, Mumps, Rubella, and Varicella Combination Vaccine: Safety and Immunogenicity Alone and in Combination with Other Vaccines Given to Children by White, C. Jo, Stinson, Diane, Staehle, Brenda, Cho, Iksung, Matthews, Holly, Ngai, Angela, Keller, Paul, Eiden, Joseph, Kuter, Barbara

“…Eight hundred and twelve children, 12 months to 3.5 years of age, were enrolled in two clinical studies to evaluate the safety and immunogenicity of a live,…”
Get full text

Modified cases of chickenpox after varicella vaccination: correlation of protection with antibody response by White, C J, Kuter, B J, Ngai, A, Hildebrand, C S, Isganitis, K L, Patterson, C M, Capra, A, Miller, W J, Krah, D L, Provost, P J

“…Four thousand forty-two healthy children and adolescents, ages 12 months to 17 years, were vaccinated with a single dose of live attenuated varicella vaccine…”
Get more information

Safety, tolerability, and immunogenicity of two regimens of Oka/Merck varicella vaccine (Varivax ®) in healthy adolescents and adults by Kuter, Barbara J., Ngai, Angela, Patterson, Carolyn M., Staehle, Brenda O., Cho, Iksung, Matthews, Holly, Provost, Philip J., Jo White, C., the Oka/Merck Varicella Vaccine Study Group

“…A multicenter clinical trial was conducted among 757 healthy adolescents and adults, 13–54 years, to compare two regimens of Oka/Merck varicella vaccine with…”
Get full text

Safety and Immunogenicity of an Inactivated Hepatitis A Vaccine among HIV-Infected Subjects by Wallace, Mark R., Brandt, Carolyn J., Earhart, Kenneth C., Kuter, Barbara J., Grosso, Anthony D., Lakkis, Hassan, Tasker, Sybil A.

“…Background. Hepatitis A is a major health risk for many human immunodeficiency virus (HIV)-infected individuals. Vaccination is a potentially attractive…”
Get full text

Safety and immunogenicity of one vs. two injections of Oka/Merck varicella vaccine in healthy children by NGAI, A. L, STAEHLE, B. O, KUTER, B. J, CYANOVICH, N. M, IKSUNG CHO, MATTHEWS, H, KELLER, P, ARVIN, A. M, WATSON, B, WHITE, C. J

“…To compare the safety and immunogenicity of a one- vs. two-dose regimen of Oka/Merck varicella vaccine in approximately 2000 healthy children 12 months to 12…”
Get full text

Childhood vaccination against varicella: Persistence of antibody, duration of protection, and vaccine efficacy by Vessey, S.J.Rupert, Chan, Christina Y., Kuter, Barbara J., Kaplan, Karen M., Waters, Marilyn, Kutzler, David P., Carfagno, Patricia A., Sadoff, Jerald C., Heyse, Joseph F., Matthews, Holly, Li, Shu, Chan, Ivan S.F.

“…Objective: To document the duration of protection afforded by Oka/Merck varicella vaccine over a 7-year period. Study design: The subjects were healthy…”
Get full text

Immunizing children to protect against the increasing risk of hepatitis A in adolescents and young adults in South Korea by SOHN, Y. M, LEE, J. S, PARK, J. H, POERSCHKE, G, EVES, K, GRESS, J, KUTER, B

“…We evaluated the CR326F strain (VAQTA) derived hepatitis A vaccine in Korean children and adolescents >2 years of age to consider a future immunization…”
Get full text

Worldwide experience with the CR326F-derived inactivated hepatitis A virus vaccine in pediatric and adult populations: an overview by Nalin, D R, Kuter, B J, Brown, L, Patterson, C, Calandra, G B, Werzberger, A, Shouval, D, Ellerbeck, E, Block, S L, Bishop, R

“…The worldwide experience to date with VAQTA, a highly purified formalin-inactivated hepatitis A vaccine containing alum-adjuvant, is reviewed. No serious…”
Get more information